Moderna announced today (January 25) plans for testing two different booster vaccines aimed at the SARS-CoV-2 variant B.1.351, also known as 501Y.V2, that emerged in South Africa and has now spread to ...

Moderna is all in on mRNA. Each of the more than 40 drugs in its pipeline relies on the technology. The company’s new ... vaccine sales have evaporated from almost $20 billion a year to about a ...

Third time's the charm! Sarah Hyland is now three-times inoculated with a COVID-19 vaccine after getting her booster shot on Wednesday ... How It Relates to Her New Movie (Exclusive) ...

With Omicron still the prevailing strain of COVID-19 around the world, the new shot is now Moderna's "lead candidate for a fall 2022 booster," he added. Some expert groups, including the Joint ...

Now, what about the second booster, which, for people who received Pfizer and Moderna, would be their ... 22 if we're going to have one or if a new vaccine for a future COVID-19 variant becomes ...

In the first quarter of the year, Moderna ... flu vaccine. The company’s RSV vaccine entered the third of five clinical research phases the Food and Drug Administration requires of new ...

As the Delta variant spreads throughout the world, the prospect of a third “booster” shot is gaining interest even in places where a large proportion of people are vaccinated. Experts say it ...

A study of “cross vaccinations” for COVID-19 found that while side effects are more prevalent when different vaccines are used for booster ... those whose third shot was a Moderna vaccine ...

The UK's Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna's bivalent COVID-19 vaccine should be used for the autumn booster campaign in adults.